Your current location：
APIs’ Intermediates Tofacitinib
Acalabrutinib
Neratinib
Upadacitinib
Bosutinib
Afatinib
Baloxavir marboxil
Elagolix
Roxadustat
Zanubrutinib
Velpatasvir
EnzalutaMide
Apalutamide
Cobicistat
Empagliflozin
Dapagliflozin
Canagliflozin
Bilastine
Hydroxychloroquine sulfate
Tolvaptan
Ribociclib
Telotristat Etiprate
Rilpivirine
Vonoprazan
Crisaborole
Efinaconazole
Pantoprazole Sodium
Other
All the intermediates of APIs listed above are only for R&D
and drug registration purpose, not for commercial use!
Shanghai Jinghao Pharmaceutical Co.,Ltd
All Right Reserved
ICP NO. 18019917
Address: Unit1， BuildingNO.1568，HaijieRoad,Haigang developmentzone,FengxianDistrict， ShanghaiCity ，China. PC.:201400
技术支持： 趣炫网络